Transitioning From Pediatric to Adult Psychiatric Care for ADHD in Sweden: A Nationwide Study DOI Creative Commons
MaiBritt Giacobini, Jianlin Zhao, Jonatan Freilich

et al.

Journal of Attention Disorders, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 25, 2024

Objective: To evaluate care transition and medication use in young adults with ADHD Sweden. Method: Observational retrospective study of patients from the Swedish National Patient Register, Prescribed Drug Cause Death Register (2018–2020). Last contact pediatric psychiatric care, first adult were described for ages 18 to 21 years, inclusive. Results: Of 19,233 who had dispensed treatment, 85.8% received by years age. The proportion on was highest at age (80.1%), decreasing 36.1% years. By there significantly more versus off healthcare autism, been prescribed selective serotonin re-uptake inhibitors, outpatient visits (all p < .0001). Conclusion: This demonstrates declining during pediatric-to-adult

Language: Английский

Online interest in ADHD predicts ADHD medication prescriptions in Australia from 2004 to 2023: A time-series analysis revealing COVID-19-related acceleration DOI Creative Commons
Luke Sy‐Cherng Woon, David Smith, Stephen Allison

et al.

Australasian Psychiatry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 18, 2025

Attention-deficit hyperactivity disorder (ADHD) medication prescriptions in Australia have grown sharply recent years. We examined the association between online interest ADHD and prescriptions. Monthly Pharmaceutical Benefits Scheme (PBS) Repatriation PBS (RPBS) Item Reports of Australian ADHD-related Google Trends (GT) data (2004-2023) were sourced. modelled lagged effect GT on prescriptions, using an autoregressive moving average model with conditional heteroskedasticity, adjusting for COVID-19 lockdown effects. Results compared to a pain-related searches PBS/RPBS opioid counterfactual alternatives: (1) (2) descriptively analysed additional news data. Annual doubled from 1,424,904 2020 3,112,072 2023. considerably increased since pandemic. had statistically significant positive Comparator models did not show associations Online supported recently public ADHD. predicts which was accentuated during Studies are needed evaluate causal pathways, health information quality sociodemographic determinants.

Language: Английский

Citations

1
Sex differences in self‐reported attention‐deficit/hyperactivity disorder symptoms in clinical and population‐based cohorts DOI Creative Commons
Berit Skretting Solberg, Maj‐Britt Posserud,

André Høberg

et al.

JCPP Advances, Journal Year: 2025, Volume and Issue: unknown

Published: March 26, 2025

Abstract Background Although the childhood prevalence of ADHD is higher in males than females, some studies suggest that females report more severe impairment related to symptoms males. The reason for this gender paradox poorly understood. Here we explored sex differences self‐reported among adolescents and adults with without an diagnosis across clinical population‐based Norwegian cohorts. Methods We analysed data from Mother, Father, Child Cohort Study (MoBa) ( N = 90,816; 62% mean age 33.4 years), youth@hordaland study (y@h) 10,257; 53% 17.4 Adults (ANA) project 1677; 55% 29.0 years). Adult Self‐Report Scale Screener (ASRS‐6) was used as outcome measure define symptom severity ADHD. Linear regression analyses were explore ASRS‐6 scores between individuals a (∆). Age‐adjusted, unstandardized coefficients (b) 95% confidence intervals (CI) reported. Results Participants reported those all three highest youngest participants, particularly y@h cohort. difference larger within cohorts, at statistically significant level both ANA (MoBa: ∆females: b 4.6 (95%CI 3.8; 5.4); ∆males: 4.2 (3.5; 5.0); y@h: 5.1 (4.0; 6.2); 3.2 (2.1; 4.2); ANA: 8.6 (8.1; 9.2); 6.5 (5.9; 7.2). Conclusions In representing different groups designs, found males, suggesting barriers referral, assessment, and/or

Language: Английский

Citations

0
A gyermekkori figyelemzavar és hiperaktivitás kezelése a magyar közfinanszírozott ellátásban DOI Creative Commons
Péter Nagy,

Gábor Bársony,

Róbert Frigyesy

et al.

IME - Az egészségügyi vezetők szaklapja, Journal Year: 2024, Volume and Issue: 23(2.), P. 49 - 58

Published: June 17, 2024

Magyarországon a gyermek- és serdülőkori figyelemzavar hiperaktivitás (attention deficit and hyperactivity disorder – ADHD) prevalenciájáról incidenciájáról populációs szintű felmérés még nem készült. Hazánkban az ADHD kezelésére metilfenidát atomoxetin hatóanyagú gyógyszerek vannak forgalomban, azonban ismert, hogy ADHD-ban érintett gyermekek közül hányan jutnak el közfinanszírozott ellátás keretében szakemberhez, mennyien részesülnek farmakoterápiában. Vizsgálatunkban célja évenkénti prevalenciájának incidenciájának meghatározása hazai keretein belül 2013–2022 időszakban, valamint gyógyszerrel kezelt arányának azonosítása. A 0–18 éves korcsoportokban megvizsgáltuk diagnózissal megjelenők egy évre vonatkoztatott standardizált tartamprevalenciáját incidenciáját. Korcsoportok, nemek régiók szerint leíró elemezéseket végeztünk, továbbá felmértük ADHD-val diagnosztizált között gyógyszeres kezelésben részesülők arányát, náluk első diagnózis gyógyszerelés megkezdése eltelt időt elsőként választott farmakoterápia típusát. Az ellátásban legalább egyszer megjelent prevalenciája 2013-tól 2022-ig folyamatos emelkedést mutat, de nemzetközi epidemiológiai adatok alapján várható mértéktől így is jelentősen elmarad (2022-ben 0,69%). incidens betegek fiúk lányok aránya 4:1, prevalens ez arány 5:1. regionális eltérések markánsak. vizsgált időszakban egyre fiatalabb korban kerültek szakemberhez. ADHD-vel 21,7%-a részesült kezelésben, többségüknél (65,0%) volt készítmény. több ADHD-s gyermek jut diagnózishoz ellátáshoz, esetek túlnyomó többsége továbbra sem jelenik meg ellátásban. farmakoterápiás gyakorlat hazánkban eltér javaslatoktól.

Citations

0
Prevalence and associated factors of ADHD-like symptoms among pharmacy students at Prince of Songkla University, Thailand in 2024: a cross-sectional study DOI Creative Commons

Krittiya Rakchat,

Saranan Eadcharoen,

Amarawan Pentrakan

et al.

The Ewha Medical Journal, Journal Year: 2024, Volume and Issue: 47(4)

Published: Oct. 21, 2024

Purpose: This study investigated the prevalence of attention-deficit/hyperactivity disorder (ADHD) and its associated factors among pharmacy students at Prince Songkla University in 2024. It was hypothesized that ADHD would be with various demographic, socioeconomic, historical, behavioral factors. Methods: cross-sectional descriptive involved from years 1-5 Thailand. Data were gathered 761 using a self-administered questionnaire included Adult Self-Report Scale (ASRS Screener V1.1). Descriptive statistics, chi-square test, Fisher exact multiple logistic regression employed for data analysis. Results: In total, 526 participated (participation rate: 69%), an average age 21 ± 1.57 years. The risk prevalent 14.4% respondents (76 students; 95% CI: 11.4%–17.5%). Significant increased identifying as non-binary or preferring not to report gender (adjusted odds ratio [ORadj], 3.32; CI, 1.04–10.57), having insufficient monthly income (ORadj, 2.02; 1.13–3.61), recent traffic violations 1.09–3.76). also found difficulties executive functioning, such organization procrastination, highly students. Conclusion: identified substantial students, including gender, financial challenges, patterns significantly this risk. These findings underscore necessity targeted mental health interventions university settings.

Language: Английский

Citations

0
Prescription drug use in Danish children and adolescents 2005–2023 DOI
Helene Kildegaard, Morten Olesen,

Tine Brink Henriksen

et al.

European Journal of Epidemiology, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 11, 2024

Language: Английский

Citations

0
Transitioning From Pediatric to Adult Psychiatric Care for ADHD in Sweden: A Nationwide Study DOI Creative Commons
MaiBritt Giacobini, Jianlin Zhao, Jonatan Freilich

et al.

Journal of Attention Disorders, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 25, 2024

Objective: To evaluate care transition and medication use in young adults with ADHD Sweden. Method: Observational retrospective study of patients from the Swedish National Patient Register, Prescribed Drug Cause Death Register (2018–2020). Last contact pediatric psychiatric care, first adult were described for ages 18 to 21 years, inclusive. Results: Of 19,233 who had dispensed treatment, 85.8% received by years age. The proportion on was highest at age (80.1%), decreasing 36.1% years. By there significantly more versus off healthcare autism, been prescribed selective serotonin re-uptake inhibitors, outpatient visits (all p < .0001). Conclusion: This demonstrates declining during pediatric-to-adult

Language: Английский

Citations

0